The application of absolute quantitative ¹H NMR spectroscopy in drug discovery and development

References

• Hollis DP. Quantitative analysis of aspirin, phenacetin, and caffeine mixtures by nuclear magnetic resonance spectrometry. Anal Chem. 1963;35:1682–1684. doi:10.1021/ac60204a043.
   Web of Science ®Google Scholar
• Hanna GMJ. Nuclear magnetic resonance spectroscopic determination of dicyclomine hydrochloride in tablet, capsule, and injection dosage forms. Anal Chem. 1984;67:222–224.
   Google Scholar
• Turczan J, Lau-Cam C. Proton magnetic resonance (PMR) spectroscopic determination of mechlorethamine hydrochloride for injection in commercial unit doses. Pharmazie. 1986;41:775–776.
   PubMed Web of Science ®Google Scholar
• Hanna GM. Determination of ephedrine, pseudoephedrine, and norephedrine in mixtures (bulk and dosage forms) by proton nuclear magnetic resonance spectroscopy. J AOAC Int. 1995;78:946–954.
   PubMed Web of Science ®Google Scholar
• Lane S, Boughtflower B, Mutton I, et al. Toward single-calibrant quantification in HPLC. A comparison of three detection strategies: Evaporative light scattering, chemiluminescent nitrogen, and proton NMR. Anal Chem. 2005;77:4354–4365. doi:10.1021/ac050257l.
   PubMed Web of Science ®Google Scholar
• Pauli GF, Jaki BU, Lankin DC. Quantitative 1H NMR: development and potential of a method for natural products analysis. J Nat Prod. 2005;68:133–149.
   PubMed Web of Science ®Google Scholar
• Holzgrabe U, Deubner R, Schollmayer C, et al. Quantitative NMR spectroscopy–applications in drug analysis. J Pharm Biomed Anal. 2005;38:806–812.
   PubMed Web of Science ®Google Scholar
• Wells RJ, Cheung J, Hook JM. The use of qNMR for the analysis of agrochemicals. In: Holzgrabe U, Wawer I, Diehl B, editors. NMR spectroscopy in pharmaceutical analysis. Amsterdam: Elsevier; 2008. p. 291–315.
   Google Scholar
• Pauli GF, Godecke T, Jaki BU, et al. Quantitative 1H NMR: development and potential of an analytical method – an update. J Nat Prod. 2012;75:834–851.
   PubMed Web of Science ®Google Scholar
• Beckonert O, Keun HC, Ebbels TM, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2:2692–2703. doi:10.1038/nprot.2007.376.
   PubMed Web of Science ®Google Scholar
• Coen M, Holmes E, Lindon JC, et al. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol. 2008;21:9–27. doi:10.1021/tx700335d.
   PubMed Web of Science ®Google Scholar
• Kaiser KA, Merrywell CE, Fang F, et al. Metabolic profiling. In: Holzgrabe U, Wawer I, Diehl B, editors. NMR spectroscopy in pharmaceutical analysis. Amsterdam: Elsevier; 2008. p. 233–267.
   Google Scholar
• Nicholson JK, Connelly J, Lindon JC, et al. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1:153–161. doi:10.1038/nrd728.
   PubMed Web of Science ®Google Scholar
• Wishart DS. Quantitative metabolomics using NMR. TrAC. 2008;27:228–237.
   Web of Science ®Google Scholar
• Wishart DS. Improving early drug discovery through ADME modelling: an overview. Drugs R D. 2007;8:349–362.
   PubMedGoogle Scholar
• Politi M, Zloh M, Pintado ME, et al. Direct metabolic fingerprinting of commercial herbal tinctures by nuclear magnetic resonance spectroscopy and mass spectrometry. Phytochem Anal. 2009;20:328–334. doi:10.1002/pca.1131.
   PubMed Web of Science ®Google Scholar
• Bernstein MA, Stefinović M, Sleigh CJ. Optimising reaction performance in the pharmaceutical industry by monitoring with NMR. Magn Reson Chem. 2007;45:564–571. doi:10.1002/mrc.2007.
   PubMed Web of Science ®Google Scholar
• Holzgrabe U. Quantitative NMR spectroscopy in pharmaceutical applications. Prog Nucl Magn Reson Spectrosc. 2010;57:229–240. doi:10.1016/j.pnmrs.2010.05.001.
   PubMed Web of Science ®Google Scholar
• Wishart DS. Applications of metabolomics in drug discovery and development. Drugs R D. 2008;9:307–322.
   PubMed Web of Science ®Google Scholar
• Lindon JC, Nicholson JK. Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery. TrAC. 2008;27:194–204.
   Web of Science ®Google Scholar
• Powers R. NMR metabolomics and drug discovery. Magn Reson Chem. 2009;47:S2–S11. doi:10.1002/mrc.2461.
   PubMed Web of Science ®Google Scholar
• Bharti SK, Roy R. Quantitative 1H NMR spectroscopy. TrAC. 2012;35:5–26.
   Web of Science ®Google Scholar
• Liu SY, Hu CQ. A comparative uncertainty study of the calibration of macrolide antibiotic reference standards using quantitative nuclear magnetic resonance and mass balance methods. Analytica Chimica Acta. 2007;602:114–121. doi:10.1016/j.aca.2007.09.009.
   PubMed Web of Science ®Google Scholar
• Pauli GF, Kuczkowiak U, Nahrstedt A. Solvent effects in the structure dereplication of caffeoyl quinic acids. Magn Reson Chem. 1999;37:827–836. doi:10.1002/(ISSN)1097-458X.
   Web of Science ®Google Scholar
• Laszlo A. Solvent effects and nuclear magnetic resonance. In: Emsley JW, Feeney J, Sutcliffe LH, editors. Progress in nuclear magnetic resonance spectroscopy. Oxford: Pregamon Press; 1967. p. 231–402.
   Google Scholar
• Branch SK, Holzgrabe U. 1H, 19F and 13C NMR spectral data of fifteen gyrase inhibitors and some metabolites. Magn Reson Chem. 1994;32:192–197. doi:10.1002/mrc.1260320313.
   Web of Science ®Google Scholar
• Amani AM. Synthesis and biological activity of piperazine derivatives of phenothiazine. Drug Res (Stuttg). 2015;65:5–8. doi:10.1055/s-0033-1364001.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Daneshtalab M. Nonclassical biological activities of quinolone derivatives. J Pharm Sci. 2012;15:52–72.
   Web of Science ®Google Scholar
• Kishimoto TK, Viswanathan K, Ganguly T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358:2457–2467. doi:10.1056/NEJMoa0803200.
   PubMed Web of Science ®Google Scholar
• Diehl B. Holzgrabe U Complexation behaviour of drugs studied by NMR. In: Holzgrabe U, Wawer I, Diehl B, editors. NMR spectroscopy in drug development and analysis. Weinheim: Wiley-VCH; 1999. p. 77–82.
   Google Scholar
• Michaleas S, Antoniadou-Vyza E. A new approach to quantitative NMR: fluoroquinolones analysis by evaluating the chemical shift displacements. J Pharm Biomed Anal. 2006;42:405–410. doi:10.1016/j.jpba.2006.04.016.
   PubMed Web of Science ®Google Scholar
• Kriat M, Confort-Gouny S, Vion-Dury J, et al. Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR Biomed. 1992;5:179–184.
   PubMed Web of Science ®Google Scholar
• Reuben J. Paramagnetic lanthanide shift reagents in NMR spectroscopy: principles, methodology and applications. Prog Nucl Magn Reson Spectrosc. 1973;9:1–70. doi:10.1016/0079-6565(73)80003-2.
   Google Scholar
• Casy AF. Chiral discrimination by NMR spectroscopy. TrAC. 1993;12:185–189.
   Web of Science ®Google Scholar
• Thunhorst M, Holzgrabe U. Utilizing NMR spectroscopy for assessing drug enantiomeric composition. Magn Reson Chem. 1998;36:211–216. doi:10.1002/(ISSN)1097-458X.
   Web of Science ®Google Scholar
• Wenzel TJ, Wilcox JD. Chiral reagents for the determination of enantiomeric excess and absolute configuration using NMR spectroscopy. Chirality. 2003;15:256–270. doi:10.1002/chir.10190.
   PubMed Web of Science ®Google Scholar
• Berger R, Courtieu J, Gil RR, et al. Is enantiomer assignment possible by NMR spectroscopy using residual dipolar couplings from chiral Nonracemic alignment media?—A critical assessment. Angew Chem Int Ed. 2012;51:8388–8391. doi:10.1002/anie.201107626.
   PubMed Web of Science ®Google Scholar
• Griffiths L, Irving AM. Assay by nuclear magnetic resonance spectroscopy: quantification limits. Analyst. 1998;123:1061–1068. doi:10.1039/a800625c.
   Web of Science ®Google Scholar
• Rundolf T, Mathiasson M, Beriroglu S, et al. Survey and qualification of internal standards for quantification by 1H NMR spectroscopy. J Pharm Biomed Anal. 2010;52:645–651. doi:10.1016/j.jpba.2010.02.007.
   PubMed Web of Science ®Google Scholar
• Akoka S, Barantin L, Trierweiler M. Concentration measurement by proton NMR using the ERETIC method. Anal Chem. 1999;71:2554–2557. doi:10.1021/ac981422i.
   PubMed Web of Science ®Google Scholar
• Farrant RD, Hollerton JC, Lynn SM, et al. NMR quantification using an artificial signal. Magn Reson Chem. 2010;48:753–762. doi:10.1002/mrc.2647.
   PubMed Web of Science ®Google Scholar
• Monakhova YB, Kohl-Himmelseher M, Kuballa T, et al. Determination of the purity of pharmaceutical reference materials by 1H NMR using the standardless PULCON methodology. J Pharm Biomed Anal. 2014;100:381–386. doi:10.1016/j.jpba.2014.08.024.
   PubMed Web of Science ®Google Scholar
• Wider G, Dreier L. Measuring protein concentrations by NMR spectroscopy. J Am Chem Soc. 2006;128:2571–2576. doi:10.1021/ja055336t.
   PubMed Web of Science ®Google Scholar
• Hoult DI. The principle of reciprocity. J Magn Reson. 2011;213:344–346. doi:10.1016/j.jmr.2011.08.005.
   PubMedGoogle Scholar
• Mehr K, John B, Russell D, et al. Electronic referencing techniques for quantitative NMR: pitfalls and how to avoid them using amplitude-corrected referencing through signal injection. Anal Chem. 2008;80:8320–8323. doi:10.1021/ac800865c.
   PubMed Web of Science ®Google Scholar
• Roumestand C, Canet D. Extending the excitation sculpting concept for selective excitation. J Magn Reson. 2000;147:331–339. doi:10.1006/jmre.2000.2206.
   PubMed Web of Science ®Google Scholar
• Adams RW, Holroyd CM, Aguilar JA. “Perfecting” WATERGATE: clean proton NMR spectra from aqueous solution. Chem Commun (Camb). 2013;49:358–360. doi:10.1039/c2cc37579f.
   PubMed Web of Science ®Google Scholar
• Simpson A, Brown S. Purge NMR: effective and easy solvent suppression. J Magn Reson. 2005;175:340–346. doi:10.1016/j.jmr.2005.05.008.
   PubMed Web of Science ®Google Scholar
• Hwang TL, Shaka AJ. Water suppression that works-excitation sculpting using arbitrary wave forms and pulsed-field gradients. J Magn Reson. 1995;112:275–279. doi:10.1006/jmra.1995.1047.
   Web of Science ®Google Scholar
• Giraudeau P. Quantitative 2D liquid-state NMR. Magn Reson Chem. 2014;52:259–272. doi:10.1002/mrc.4068.
   PubMed Web of Science ®Google Scholar
• Martineau E, Tea I, Akoka S, et al. Absolute quantification of metabolites in breast cancer cell extracts by quantitative 2D 1H INADEQUATE NMR. NMR Biomed. 2012;25:985–992. doi:10.1002/nbm.1816.
   PubMed Web of Science ®Google Scholar
• Keifer PA. NMR spectroscopy in drug discovery: tools for combinatorial chemistry, natural products, and metabolism research. Prog Drug Res. 2000;55:137–211.
   PubMedGoogle Scholar
• Chauthe SK, Sharma RJ, Aqil F, et al. Quantitative NMR: an applicable method for quantitative analysis of medicinal plant extracts and herbal products. Phytochem Anal. 2012;23:689–696. doi:10.1002/pca.2375.
   PubMed Web of Science ®Google Scholar
• Gödecke T, Yao P, Napolitano JG, et al. Integrated standardization concept for Angelica botanicals using quantitative NMR. Fitoterapia. 2012;83:18–32. doi:10.1016/j.fitote.2011.08.017.
   PubMed Web of Science ®Google Scholar
• Napolitano JG, Gödecke T, Rodríguez-Brasco MF, et al. The tandem of full spin analysis and qHNMR for the quality control of botanicals exemplified with Ginkgo biloba. J Nat Prod. 2012;75:238–248. doi:10.1021/np200949v.
   PubMed Web of Science ®Google Scholar
• Simmler C, Napolitano JG, McAlpine JB, et al. Universal quantitative NMR analysis of complex natural samples. Curr Opin Biotechnol. 2014;25:51–59. doi:10.1016/j.copbio.2013.08.004.
   PubMed Web of Science ®Google Scholar
• Bohni N, Cordero-Maldonado ML, Maes J, et al. Integration of Microfractionation, qNMR and Zebrafish screening for the in vivo bioassay-guided isolation and quantitative bioactivity analysis of natural products. Plos One. 2013;8:e64006. doi:10.1371/journal.pone.0064006.
   Google Scholar
• Robinette SL, Brüschweiler R, Schroeder F, et al. NMR in metabolomics and natural products research: two sides of the same coin. Acc Chem Res. 2012;45:288–297. doi:10.1021/ar2001606.
   PubMed Web of Science ®Google Scholar
• Holzgrabe U, Diehl BW, Wawer I. NMR spectroscopy in pharmacy. J Pharm Biomed Anal. 1998;17:557–616.
   PubMed Web of Science ®Google Scholar
• Hanna GM, Lau-Cam CA. Determination of chlorpheniramine maleate in tablets and injections by1H NMR spectroscopy. J Pharm Biomed Anal. 1993;11:855–859.
   PubMed Web of Science ®Google Scholar
• Schmedake TA, Welch LE. The quantitative analysis of an analgesic tablet: an NMR experiment for the instrumental analysis course. J Chem Educ. 1996;73:1045–1048.
   Web of Science ®Google Scholar
• Turczan JW. Nuclear magnetic resonance analysis of pharmaceuticals. XI. Determination of acetazolamide and its sodium salt in various dosage forms. Anal Chim Acta. 1974;68:395–400.
   PubMed Web of Science ®Google Scholar
• Baker JK, Myers CW. One-dimensional and two-dimensional 1H- and 13C-nuclear magnetic resonance (NMR) analysis of vitamin E raw materials or analytical reference standards. Pharm Res. 1991;8:763–770.
   PubMed Web of Science ®Google Scholar
• Turczan JW, Medwick T. NMR analysis of pharmaceuticals. XII. Determination of amantadine hydrochloride in soft gelatin capsules and syrups. J Pharm Sci. 1974;63:425–427.
   PubMed Web of Science ®Google Scholar
• Beyer T, Diehl B, Randel G, et al. Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal. 2008;48:13–19.
   PubMed Web of Science ®Google Scholar
• Seo S, Englund JA, Nguyen JT, et al. Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics. Antivir Ther. 2013;18:377–386.
   PubMed Web of Science ®Google Scholar
• Malkani R, Zadikoff C, Melen O, et al. Amantadine for freezing of gait in patients with Parkinson disease. Clin Neuropharmacol. 2012;35:266–268.
   PubMed Web of Science ®Google Scholar
• Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008;4:1119–1129.
   PubMed Web of Science ®Google Scholar
• Cicero AF, Gerocarni B, Rosticci M, et al. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice. Clin Exp Hypertens. 2012;34:113–117.
   PubMed Web of Science ®Google Scholar
• McCormack PL, Plosker GL. Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer. Drug. 2006;66:711–728.
   PubMed Web of Science ®Google Scholar
• Rossini M, Orsolini G, Adami S, et al. Osteoporosis treatment: why ibandronic acid? Expert Opin Pharmacother. 2013;14:1371–1381.
   PubMed Web of Science ®Google Scholar
• Dawson BA, Black DB, Neville GA. Multinuclear NMR (1H, 13C and 19F) spectroscopic re-examination of the solvolytic behaviour of flurazepam dihydrochloride. J Pharm Biomed Anal. 1995;13:395–407.
   PubMed Web of Science ®Google Scholar
• Neville GA, Beckstead HD, Black DB, et al. Vibrational and NMR spectroscopic study of aged flurazepam mono- and dihydrochloride salts for content identity. J Pharm Sci. 1994;83:1274–1279.
   PubMed Web of Science ®Google Scholar
• Inkmann E, Holzgrabe U, Hesse KF. Stability of mono- and bisbenzyloxime ethers of the acetylcholinesterase reactivator TMB-4. Pharmazie. 1997;52:764–774.
   PubMed Web of Science ®Google Scholar
• Sadana GS, Ghogare AB. Quantitative proton magnetic resonance spectroscopic determination of nifedipine and its photodecomposition products from pharmaceutical preparations. J Pharm Sci. 1991;80:895–898.
   PubMed Web of Science ®Google Scholar
• Skordi E, Wilson ID, Lindon JC, et al. Characterization and quantification of metabolites of racemic ketoprofen excreted in urine following oral administration to man by 1H-NMR spectroscopy, directly coupled HPLC-MS and HPLC-NMR, and circular dichroism. Xenobiotica. 2004;34:1075–1089.
   PubMed Web of Science ®Google Scholar
• Nieddu M, Carta A, Burrai L, et al. Screening method for five commonly used amphetamines in urine by NMR spectroscopy. Appl Magn Reson. 2014;45:135–144.
   Web of Science ®Google Scholar
• Baranova A, Huang BT, Kocak A, et al. Quantitation of amoxicillin in urine by nuclear magnetic resonance. Application to five cases. J Clin Anal Med. 2016;7:65–69.
   Google Scholar
• Wilson ID, Nicholson JK. Solid phase extraction chromatography and NMR spectroscopy (SPEC-NMR) for the rapid identification of drug metabolites in urine. J Pharm Biomed Anal. 1988;6:151–165.
   PubMed Web of Science ®Google Scholar
• Hanna GM, Lau-Cam CA. Optical purity determination of threo-methylphenidate hydrochloride using a chiral europium nuclear magnetic resonance (NMR) shift reagent. Pharm Res. 1990;7:726–729.
   PubMed Web of Science ®Google Scholar
• Hanna GM, Lau-Cam CA, Plank WM. Direct determination of the enantiomeric purity of tramadol hydrochloride by proton nuclear resonance (1H NMR) spectroscopy with chiral lanthanide shift reagent. Pharmazie. 1989;44:321–325.
   Web of Science ®Google Scholar
• Hanna GM, Lau-Cam CA. Determination of the optical purity of indacrinonebyproton nuclear magnetic resonance spectroscopy using chiral lanthanidechelates. J Pharm Biomed Anal. 1989;7:919–928.
   PubMed Web of Science ®Google Scholar
• Hanna GM, Lau-Cam CA. Determination of the optical purity of timolol maleate by proton nuclear magnetic resonance spectroscopy with a chiral Pr(III) shift reagent. J Pharm Biomed Anal. 1995;13:1313–1319.
   PubMed Web of Science ®Google Scholar
• Hanna GM. Determination of enantiomeric composition of ibuprofen in bulk drug by proton nuclear magnetic resonance spectroscopy with a chiral lanthanide chelate. J Pharm Biomed Anal. 1997;15:1805–1811.
   PubMed Web of Science ®Google Scholar
• Marchant CA, Branch SK. 1D and 2D proton NMR studies of the chiral recognition of flurbprofen by β-cyclodextrin. J Pharm Pharmacol. 1990;42:P68.
   PubMed Web of Science ®Google Scholar
• Ndou TT, Mukundan S Jr, Warner IM. Complexation of ephedrine withβ-cyclodextrin: an NMR spectroscopy study. J Incl Phenom. 1993;15:9–25.
   Web of Science ®Google Scholar
• Wiese M, Cordes HP, Chi H, et al. Interaction of prostaglandin E1, with α-cyclodextrin in aqueous systems: stability of the inclusion complex. J Pharm Sci. 1991;80:153–156.
   PubMed Web of Science ®Google Scholar
• Casy AF, Drake AF, Ganellin CR, et al. Stereochemical studies of chiral h-1 antagonists of histamine: the resolution, chiral analysis, and biological evaluation of four antipodal pairs. Chirality. 1992;4:356–366.
   PubMed Web of Science ®Google Scholar
• Moyano JR, Arias-Blanco MJ, Gines JM, et al. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with β-cyclodextrin. J Pharm Sci. 1997;86:72–75.
   PubMed Web of Science ®Google Scholar
• Casy AF, Cooper AD, Jefferies TM, et al. HPLC and 1H-NMR study of chiral recognition in some thromboxane antagonists induced by β-cyclodextrin. J Pharm Biomed Anal. 1991;9:787–792.
   PubMed Web of Science ®Google Scholar
• Easton CJ, Lincoln SF. Chiral discrimination by modified cyclodextrins. Chem Soc Rev. 1996;1:163–170.
   Web of Science ®Google Scholar
• Lin M, Tesconi M, Tischler M. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds. Int J Pharm. 2009;369:47–52.
   PubMed Web of Science ®Google Scholar
• Sun D, Yu LX, Hussain MA, et al. In vitro testing of drug absorption for drug ‘developability’ assessment: forming an interface between in vitro preclinical data and clinical outcome. Cur Opin Drug Disc Dev. 2004;7:75–85.
   PubMed Web of Science ®Google Scholar
• Huynh-Ngoc T, Sirios G. NMR quantitative analysis of quinidine in mixtures of quinidine and hydroquinidine. J Pharm Sci. 1973;62:1334–1336.
   PubMed Web of Science ®Google Scholar
• Cullen CH, Ray GJ, Szabo CM. A comparison of quantitative nuclear magnetic resonance methods: internal, external, and electronic referencing. Magn Reson Chem. 2013;51:705–713.
   PubMed Web of Science ®Google Scholar
• Walker GS, Bauman JN, Ryder TF, et al. Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies. Drug Metab Dispos. 2014;42:1627–1639.
   PubMed Web of Science ®Google Scholar
• Mutlib A, Espina R, Vishwanathan K, et al. Application of quantitative NMR in pharmacological evaluation of biologically generated metabolites: implications in drug discovery. Drug Metab Dispos. 2011;39:106–116.
   PubMed Web of Science ®Google Scholar
• Do NM, Olivier MA, Salisbury JJ, et al. Application of quantitative 19F and 1H NMR for reaction monitoring and in situ yield determinations for an early stage pharmaceutical candidate. Anal Chem. 2011;83:8766–8771.
   PubMed Web of Science ®Google Scholar
• Lerche MH, Meier S, Jensen PR, et al. Quantitative dynamic nuclear polarization-NMR on blood plasma for assays of drug metabolism. NMR Biomed. 2011;24:96–103.
   PubMed Web of Science ®Google Scholar